Fintan steele biography template

Prior to joining SomaLogic, Dan was CFO of bio-industrial company OPX Biotechnologies, where he closed $47 million in equity and debt financing;.

Progress towards realization of a personalized medicine vision will require the active cooperation of all stakeholders in the healthcare ecosystem.

DNA can drive diseases such as cystic fibrosis or Tay Sachs, but people with mutations in these very genes can surprisingly be healthy, says Fintan Steele, PhD.

•

Significance

Aptamers are now used ubiquitously as binding agents for a broad range of applications. Natural (unmodified) DNA and RNA aptamers have considerably less chemical diversity than protein-based ligands such as antibodies, limiting their utility. Aptamers possessing a single chemical modification have helped bridge this diversity gap. We report the selection and identification of aptamers with two diversity-enhancing chemical modifications that bind and inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9), a representative human therapeutic protein target. The addition of a second modification, especially in certain pairwise combinations, resulted in significant improvements in affinity, ligand efficiency, epitope coverage, metabolic stability, and inhibitory activity. Extensively chemically functionalized aptamers have the potential to become the next generation of nucleic-acid–based ligands.

Keywords: SELEX, modified aptamer, PCSK9, SOMAmer, PSMA

Abstract

•

US6204248B1 - Pharmaceutical preparations of glutathione and methods of administration thereof - Google Patents

Pharmaceutical preparations of glutathione and methods of ledning thereof Download PDF

Info

Publication number: US6204248B1
Authority: US; United States
Prior art keywords: glutathione; gsh; cells; cell; redox
Prior art date
Legal ställning eller tillstånd (The legal status fryst vatten an assumption and fryst vatten not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the ställning eller tillstånd listed.): Expired - Lifetime

Application number

US09/457,642

Inventor

Harry B. Demopoulos

Myron L. Seligman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

ANTIOXIDANT PHAMACE

•

Latest Comments

Popular Tags Career Development Fund WDPD2024 Rapid Assessment Model Maturity Modelling Environmental Sustainability Access, Use and Reuse Advocacy Access WDPD Webinar

Archives

December, 2022
November, 2022
October, 2022
September, 2022
August, 2022
July, 2022
June, 2022
May, 2022
April, 2022
March, 2022
February, 2022
January, 2022
December, 2021
November, 2021
October, 2021
September, 2021
August, 2021
July, 2021
June, 2021

May, 2021
April, 2021
March, 2021
February, 2021
January, 2021
December, 2020
November, 2020
October, 2020
September, 2020
August, 2020
July, 2020
June,